Lineage Cell Therapeutics
LCTX
$1.09
Share price
-3.54%
Change (1 day)
-16.79%
Change (1 year)
Categories
Lineage Cell Therapeutics (LCTX) - Total debt
Total debt on the balance sheet as of December 2023 : $2.95 M
According to Lineage Cell Therapeutics 's latest financial reports the company's total debt is $2.95 M. A company’s total debt is the sum of all current and non-current debts.
Lineage Cell Therapeutics - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $2.95 M | -24.23% |
| 2022-12-31 | $3.89 M | 39.04% |
| 2021-12-31 | $2.8 M | -26.75% |
| 2020-12-31 | $3.82 M | -25.99% |
| 2019-12-31 | $5.16 M | 128.17% |
| 2018-12-31 | $2.26 M | 47.75% |
| 2017-12-31 | $1.53 M | -61.5% |
| 2016-12-31 | $3.98 M | -21.97% |
| 2015-12-31 | $5.1 M | 868.31% |
| 2014-12-31 | $0.52 M | |
| 2013-12-31 | $N/A | |
| 2008-12-31 | $1.88 M | 163.17% |
| 2007-12-31 | $0.71 M | |
| 2003-12-31 | $2.68 M | 23.82% |
| 2002-12-31 | $2.16 M | 25.28% |
| 2001-12-31 | $1.73 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | -6.78% | 🇺🇸 USA |